Abstract
A new grading classification for pancreatic neuroendocrine tumors (pNET) was proposed by the World Health Organization (WHO) in 2010 (2010 WHO classification). pNET are classified as neuroendocrine tumors (NET) G1, NET G2, and neuroendocrine carcinoma (NEC) based on the proliferative indices. It has been shown that EUS-FNA is useful to diagnose several types of pancreatic tumors histologically, but it is still controversial whether EUS-FNA using a 22-gauge (G) needle is useful to diagnose pNET.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
